Stock CLS B CLINICAL LASERTHERMIA SYSTEMS AB
Add to a list
To use this feature you must be a member
Log inSign up

All News Clinical Laserthermia Systems AB

Equities

CLS B

SE0022049920

Market Closed - Nasdaq Stockholm
Other stock markets
 16:29:48 24/05/2024 BST 		5-day change 1st Jan Change
19.88 SEK +15.05% Intraday chart for Clinical Laserthermia Systems AB +42.02% -27.97%
05-14 Clinical Laserthermia Systems AB Enters into an Exclusive Distribution Agreement with MTEC Company CI
04-30 Clinical Laserthermia Notes US FDA Clearance for ClearPoint's Prism Bone Anchor Accessory MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
BioStock: CLS revises strategy - increases focus on neurosurgery
AQ
CLS focuses on the Neurosurgery business area to optimize capital allocation, secure profitability targets and implement associated cost savings
AQ
BioStock: CLS launches in France
AQ
CLS launches its Focal Laser Ablation system for prostate cancer in France in collaboration with MTEC Company
AQ
Clinical Laserthermia Systems AB Enters into an Exclusive Distribution Agreement with MTEC Company
CI
Clinical Laserthermia Notes US FDA Clearance for ClearPoint's Prism Bone Anchor Accessory
MT
CLS partner ClearPoint Neuro receives FDA 510(k) clearance for Prism Bone Anchor Accessory enabling operating room placement of laser applicators
AQ
Clinical Laserthermia Systems announces timetable and additional information for the upcoming reverse share split
AQ
Bulletin from the Extraordinary General Meeting on Friday 12th of April in Clinical Laserthermia Systems AB
AQ
BioStock: CLS makes progress in prostate cancer in Europe and the US
AQ
Initial data presented from the Investigator Initiated Trial (IIT) at Radboud University Medical Center using the CLS TRANBERG[®] system
AQ
Clinical Laserthermia Systems AB Presents Initial Data from the Investigator Initiated Trial at Radboud University Medical Center Using the CLS Transberg System
CI
CLS receives second order from the National Institutes of Health Clinical Center in the US
AQ
Clinical Laserthermia Systems Receives Second Order from the National Institutes of Health Clinical Center in the US for its TRANBERG Thermal Therapy System Accessories
CI
As part of CLS expansion in Europe prostate cancer patients have been treated with CLS TRANBERG Thermal Therapy System for the first time in Italy
AQ
Clinical Laserthermia Systems AB Announces Two Patients with Localized Prostate Cancer Have Been Safely Treated with the Tranberg Thermal Therapy System At the San Luigi Gonzaga University Hospital in Turin, Italy
CI
CLS signs agreement with ROSE Urology for treatment of prostate cancer patients with TRANBERG Thermal Therapy System
AQ
Clinical Laserthermia Systems AB's Subsidiary CLS Americas Signs Agreement with ROSE Urology for Treatment of Prostate Cancer Patients with TRANBERG Thermal Therapy System
CI
Clinical Laserthermia Systems Names Interim CFO
MT
CLS appoints Håkan Rosqvist as interim CFO
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CLS B Stock
  4. News Clinical Laserthermia Systems AB